Participants are sought for the regulation of what future AI-powered nanomedicines should look like

Participants are sought for the regulation of what future AI-powered nanomedicines should look like

June 14, 2022

(Nanowerk News) Would you like to help with some research on the regulation of what future AI-powered nanomedicines should look like? If so, researchers at the University of Bristol are looking for volunteers to discuss ethical and regulatory issues surrounding the use of AI-driven cancer therapies through swarm behavior through a series of interviews.

The research is part of SWARM studySshopping center robots Wthe collective behavior that AI-driven cancer therapies; building Rcalculations for future nanoMmedicines.

Researchers are looking for:

  • -Oncological healthcare staff
  • – Cancer patients
  • – Regulators or decision makers in drug delivery / oncology
  • -Nanomedical researcher or developer
  • Volunteers must be over 18 years old to participate. We would love to hear from you. You can find out more about the study on our SWARM study website or by contacting Matimba Swana at [email protected]

    If you want to join, fill in this Form for registration of interest.

    About the SWARM study

    Cancer Nanomedicine

    Cancer occurs when abnormal cells divide in an uncontrolled manner. Many cancers can be cured. But in some people, cancer can return. Cancer drugs, like chemotherapy, must be able to kill all cancer cells, but that means they can also kill healthy cells.

    Nanomedicine is the medical application of nanotechnology that works in small scales called “nanometers” (one billionths of a meter). Nanoparticles are nanosized particles that can help deliver chemotherapy drugs to cancer cells. Researchers and engineers can use simulations to select nanoparticles so that drugs can reach the tumor more efficiently while avoiding side effects. Nanoswarms

    Using simulations, researchers and engineers are working to add swarm behavior (found in social animals such as birds, ants, fish and termites) to nanoparticles and small robots (nanobots). Nanosworms are multiple nanoparticles or nanobots that can interact with each other or their environment to accomplish a task (such as delivering chemotherapy to a tumor without killing healthy cells), which exhibits a collective behavior inspired by swarm behavior. SWARM study – goals & research question

    This project examines the ethics and rules of the first clinical trial of nanosworms in humans. We will use initial interviews and focus groups in the next phase to explore stakeholders’ attitudes to this swarm technology in healthcare, combined with ethical / legal analysis to consider how swarm medicine should be regulated in clinical trials.

    The aim is to explore how nanoswarm medicine should be regulated when this technology is available for the first time in clinical trials on humans. Researcher

    This study is organized by Matimba Swana, PhD student in Trustworthy Autonomous Systems in Functionality Node and Academic Supervisors; Dr. Sabine Hauert, reader (associate professor) in Swarm Engineering and prof. Jonathan Ives, Professor of Empirical Bioethics and Deputy Director of the Center for Ethics in Medicine.

    Do you want to participate?

    If you are 18 years or older, we would like to hear from you. For the interviews, we are looking for oncology healthcare staff or oncology patients or those who work with the regulation of drug deliveries or in nanomedical research. You do not need to have any prior knowledge of nanoswarmers to participate as we will show you case studies to introduce you to the techniques.

    Your contribution would be very helpful! For more information please contact Matimba Swana at [email protected] OR fill out this form for registering interests for interviews.

    We are still in the first phase of this study, so we will not start interviews until later in the year, but fill in the registration of interest for interviews and we will contact you to book an interview. We will start recruiting to focus groups in early 2023.

    Five fun facts

  • The word swarm comes from the old English word swearfinally from the proto-Indo-European * swer- (â € œto buzz, humâ €), which is believed to have been spoken as a single language 4500 BC. to 2500 BC.
  • A swarm is a large or dense group.
  • Swarming behavior, or swarming, is a collective behavior that is common in biology, from cell colonies to insect swarms and flocks of birds.
  • The term “swarm” is also used on artificial devices that mimic collective behaviors, such as in a robot swarm.
  • Swarming behavior was first simulated on a computer in 1986 with the simulation program boids (an artificial life program that stimulates the birds’ flocking behavior).
  • The SWARM study is part of a larger UKRI-funded doctoral dissertation that is part of the Trustworthy Autonomous Systems Node in Functionality research program, which is an interdisciplinary collaboration between ethicists, sociologists, computer scientists and engineers who work together to develop guidelines for the development of credible autonomous systems with changing functionality.

    Research ethics approval

    This project has been reviewed and approved by the University of Bristol Faculty of Engineering Research Ethics Committee (Ref: 11141).

    Find out more before participating from these PDFs:

    SWARM study summary

    SWARM flyer Interviews

    Participant information Magazine for interviews

    SWARM flyer focus groups

    Participant information for focus groups (will be live when the interviews are completed)

    Registration of interest for focus groups (comes live when the interviews are finished)

    #Participants #sought #regulation #future #AIpowered #nanomedicines

    Leave a Comment

    Your email address will not be published.